BioSpace News Archive

Designation based on unprecedented results from the Phase III ADAURA trial where TAGRISSO reduced the risk of disease recurrence or death by c. 80%

American Gene Technologies (AGT), an internationally recognized advanced gene and cell therapy company in Rockville, MD, today announced a coauthored article by scientists from AGT and the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), regarding AGT’s promising cell and gene therapy for HIV. Through a collaboration agreement initiated in 2019 between AGT and NIAID, gover

The “good” bacteria living in our guts do much more than help us digest food and build up our immune systems, some bacteria also play a vital role in helping heal damaged intestinal tissues, according to a surprising study published online July 30, 2020, in the journal Nature.

Vituity , a nationwide, physician-owned-and-led multispecialty partnership, and GEn1E Lifesciences , a Y Combinator and StartX company focused on accelerating cures for diseases of inflammation and aging, today announced a new strategic partnership t

Ra Medical Systems, Inc. (“Ra Medical”) (NYSE: RMED), a commercial-stage medical device company leveraging its advanced excimer laser-based platform for use in the treatment of vascular and dermatological immune-mediated inflammatory diseases, today announced that it has priced a public offering of an aggregate of 34,285,714 shares of common stock (or common stock equivalents),

In lieu of an in-person update to the media, Dr. Theresa Tam, Canada’s Chief Public Health Officer, issued the following statement

Phylagen, an award-winning biotech company specializing in decoding the environmental microbiome for indoor safety, today announced the national availability of its Phylagen Surface™ SARS-CoV-2 (COVID-19) test kit.

Ethicon*, part of the Johnson & Johnson Medical Devices Company**, announced the U.S. Food and Drug Administration (FDA) has granted Breakthrough Device Designation for transbronchial microwave ablation technology using robotic-assisted bronchoscopy, which is currently under development.

Syros Pharmaceuticals (NASDAQ:SYRS), a leader in the development of medicines that control the expression of genes, today announced that it will host a live conference call and webcast at 8:30 a.m. ET on Thursday, August 6, 2020 to report its second quarter 2020 financial results and provide a corporate update. To access the live conference call, please dial 866-595-4538 (domestic) or 636-812-6496 (international),

Masimo (NASDAQ: MASI) today announced that it has entered into a partnership with the National Basketball Association (NBA) to be its official supplier of pulse oximetry. As teams return to play, Masimo is supplying the NBA with MightySat ® fingertip pulse oximeters on its campus in Orlando, Florida. This press release features multi